Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05134857 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Zonisamide and Reinforcement for Reducing Alcohol Use (ZARRA) Study

StatusActive, Not Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion pushed from Aug 31, 2026 to Aug 31, 2027v7
  2. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v6
  3. Re-verified, no change to tracked fieldsv5
  4. Primary and study completion dates: Aug 2025 to Aug 31, 2026v4
  5. Re-verified, no change to tracked fieldsv3
  6. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Dec 2021 to Jan 7, 2022
    • Site details revised
    v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A phase II randomized, double-blind, placebo-controlled clinical trial (RCT) to evaluate the ability of zonisamide (ZON) to decrease alcohol use among treatment-seeking adults with an alcohol use disorder (AUD).
Trial Details
NCT Number NCT05134857
Lead Sponsor Washington State University
Conditions
(from sponsor)		 Alcohol Use Disorder (AUD)
Related terms Alcoholism
Enrollment 205 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov